Literature DB >> 20237409

Resistance to thyroid hormone is associated with raised energy expenditure, muscle mitochondrial uncoupling, and hyperphagia.

Catherine S Mitchell1, David B Savage, Sylvie Dufour, Nadia Schoenmakers, Peter Murgatroyd, Douglas Befroy, David Halsall, Samantha Northcott, Philippa Raymond-Barker, Suzanne Curran, Elana Henning, Julia Keogh, Penny Owen, John Lazarus, Douglas L Rothman, I Sadaf Farooqi, Gerald I Shulman, Krishna Chatterjee, Kitt Falk Petersen.   

Abstract

Resistance to thyroid hormone (RTH), a dominantly inherited disorder usually associated with mutations in thyroid hormone receptor beta (THRB), is characterized by elevated levels of circulating thyroid hormones (including thyroxine), failure of feedback suppression of thyrotropin, and variable tissue refractoriness to thyroid hormone action. Raised energy expenditure and hyperphagia are recognized features of hyperthyroidism, but the effects of comparable hyperthyroxinemia in RTH patients are unknown. Here, we show that resting energy expenditure (REE) was substantially increased in adults and children with THRB mutations. Energy intake in RTH subjects was increased by 40%, with marked hyperphagia particularly evident in children. Rates of muscle TCA cycle flux were increased by 75% in adults with RTH, whereas rates of ATP synthesis were unchanged, as determined by 13C/31P magnetic resonance spectroscopy. Mitochondrial coupling index between ATP synthesis and mitochondrial rates of oxidation (as estimated by the ratio of ATP synthesis to TCA cycle flux) was significantly decreased in RTH patients. These data demonstrate that basal mitochondrial substrate oxidation is increased and energy production in the form of ATP synthesis is decreased in the muscle of RTH patients and that resting oxidative phosphorylation is uncoupled in this disorder. Furthermore, these observations suggest that mitochondrial uncoupling in skeletal muscle is a major contributor to increased REE in patients with RTH, due to tissue selective retention of thyroid hormone receptor alpha sensitivity to elevated thyroid hormone levels.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20237409      PMCID: PMC2846038          DOI: 10.1172/JCI38793

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  60 in total

1.  Characterization of seven novel mutations of the c-erbA beta gene in unrelated kindreds with generalized thyroid hormone resistance. Evidence for two "hot spot" regions of the ligand binding domain.

Authors:  R Parrilla; A J Mixson; J A McPherson; J H McClaskey; B D Weintraub
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

Review 2.  Energy expenditure and fuel selection in biological systems: the theory and practice of calculations based on indirect calorimetry and tracer methods.

Authors:  M Elia; G Livesey
Journal:  World Rev Nutr Diet       Date:  1992       Impact factor: 0.575

3.  Dietary reference values for food energy and nutrients for the United Kingdom. Report of the Panel on Dietary Reference Values of the Committee on Medical Aspects of Food Policy.

Authors: 
Journal:  Rep Health Soc Subj (Lond)       Date:  1991

4.  Skeletal muscle metabolism is a major determinant of resting energy expenditure.

Authors:  F Zurlo; K Larson; C Bogardus; E Ravussin
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

5.  Dominant negative transcriptional regulation by a mutant thyroid hormone receptor-beta in a family with generalized resistance to thyroid hormone.

Authors:  A Sakurai; T Miyamoto; S Refetoff; L J DeGroot
Journal:  Mol Endocrinol       Date:  1990-12

6.  Thyroid hormone resistance syndrome. Inhibition of normal receptor function by mutant thyroid hormone receptors.

Authors:  V K Chatterjee; T Nagaya; L D Madison; S Datta; A Rentoumis; J L Jameson
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

7.  Determinants of 24-hour energy expenditure in man. Methods and results using a respiratory chamber.

Authors:  E Ravussin; S Lillioja; T E Anderson; L Christin; C Bogardus
Journal:  J Clin Invest       Date:  1986-12       Impact factor: 14.808

8.  Identification of a novel mutation in the gene encoding the beta-triiodothyronine receptor in a patient with apparent selective pituitary resistance to thyroid hormone.

Authors:  A J Mixson; J C Renault; S Ransom; D L Bodenner; B D Weintraub
Journal:  Clin Endocrinol (Oxf)       Date:  1993-03       Impact factor: 3.478

9.  Functional relationship of thyroid hormone-induced lipogenesis, lipolysis, and thermogenesis in the rat.

Authors:  J H Oppenheimer; H L Schwartz; J T Lane; M P Thompson
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

10.  Thyroid hormone-related regulation of gene expression in human fatty liver.

Authors:  Jussi Pihlajamäki; Tanner Boes; Eun-Young Kim; Farrell Dearie; Brian W Kim; Joshua Schroeder; Edward Mun; Imad Nasser; Peter J Park; Antonio C Bianco; Allison B Goldfine; Mary Elizabeth Patti
Journal:  J Clin Endocrinol Metab       Date:  2009-06-23       Impact factor: 5.958

View more
  41 in total

Review 1.  Thyroid hormones and thyroid hormone receptors: effects of thyromimetics on reverse cholesterol transport.

Authors:  Matteo Pedrelli; Camilla Pramfalk; Paolo Parini
Journal:  World J Gastroenterol       Date:  2010-12-21       Impact factor: 5.742

Review 2.  New insights into regulation of lipid metabolism by thyroid hormone.

Authors:  Xuguang Zhu; Sheue-yann Cheng
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2010-10       Impact factor: 3.243

3.  Emerging Pharmacological Targets for the Treatment of Nonalcoholic Fatty Liver Disease, Insulin Resistance, and Type 2 Diabetes.

Authors:  Leigh Goedeke; Rachel J Perry; Gerald I Shulman
Journal:  Annu Rev Pharmacol Toxicol       Date:  2019-01-06       Impact factor: 13.820

Review 4.  Clinical Consequences of Mutations in Thyroid Hormone Receptor-α1.

Authors:  Alies A van Mullem; Theo J Visser; Robin P Peeters
Journal:  Eur Thyroid J       Date:  2014-03-14

5.  Resistance to thyroid hormone is modulated in vivo by the nuclear receptor corepressor (NCOR1).

Authors:  Laura Fozzatti; Changxue Lu; Dong Wook Kim; Jeong Won Park; Inna Astapova; Oksana Gavrilova; Mark C Willingham; Anthony N Hollenberg; Sheue-yann Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-10       Impact factor: 11.205

6.  Resistance to thyroid hormone--an incidental finding.

Authors:  Donna Chantler; Carla Moran; Erik Schoenmakers; Stephen Cleland; Maurizio Panarelli
Journal:  BMJ Case Rep       Date:  2012-03-27

7.  Assessing the clinical and molecular diagnosis of inherited forms of impaired sensitivity to thyroid hormone from a single tertiary center.

Authors:  Luciano S Ramos; Marina M L Kizys; Ilda S Kunii; Angela M Spinola-Castro; Suzana Nesi-França; Ricardo A Guerra; Cleber P Camacho; João R M Martins; Rui M B Maciel; Magnus R Dias-da-Silva; Maria I Chiamolera
Journal:  Endocrine       Date:  2018-07-19       Impact factor: 3.633

8.  Thyroid Hormone Signaling in Muscle Development, Repair and Metabolism.

Authors:  Jang-Won Lee; Nam-Ho Kim; Anna Milanesi
Journal:  J Endocrinol Diabetes Obes       Date:  2014 Jul-Sep

9.  Thyroid hormone signaling in vivo requires a balance between coactivators and corepressors.

Authors:  Kristen R Vella; Preeti Ramadoss; Ricardo H Costa-E-Sousa; Inna Astapova; Felix D Ye; Kaila A Holtz; Jamie C Harris; Anthony N Hollenberg
Journal:  Mol Cell Biol       Date:  2014-02-18       Impact factor: 4.272

10.  Periodic Paralysis as a New Phenotype of Resistance to Thyroid Hormone Syndrome in a Chinese Male Adult.

Authors:  Shikun Ma; Mingming Hu; Hongbo Yang; Xiaolan Lian; Yanqiu Jiang
Journal:  J Clin Endocrinol Metab       Date:  2015-12-10       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.